類風濕性關節炎(RA)診斷檢驗市場:檢驗各類型，各終端用戶，各地區-市場規模，佔有率，展望，機會分析，2023-2030年

Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test, Monitoring RA Treatment Efficiency Tests ), By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

主要市場參與者正專注於採用有機增長策略，例如推出類風濕關節炎診斷血液測試，這歸因於全球類風濕關節炎診斷測試市場的增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球類風濕性關節炎(RA)診斷檢驗市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球類風濕性關節炎(RA)診斷檢驗市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球類風濕性關節炎(RA)診斷檢驗市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球類風濕性關節炎(RA)診斷檢驗市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

企業簡介
- Abbott Diagnostics(Abbott Laboratories)
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB,
- F.Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC(imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

第9章章節

參考文獻
調查手法

簡介目錄

Product Code: CMI3716

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease, which means that your immune system attacks healthy cells in your body by mistake, causing inflammation (painful swelling) in the affected parts of the body. RA mainly attacks the joints, usually many joints at once. RA commonly affects joints in the hands, wrists, and knees. In a joint with RA, the lining of the joint becomes inflamed, causing damage to joint tissue. This tissue damage can cause long-lasting or chronic pain, unsteadiness (lack of balance), and deformity (misshapenness).RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart, and eyes.Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. The rheumatoid arthritis diagnostic tests market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally.

Market Dynamics

The key market players are focusing on adoption of growth organic strategies such launching of diagnostic blood test for rheumatoid arthritis, which is attributed to the growth of global rheumatoid arthritis diagnostic tests market. For instance, in March 2020, BD (Becton, Dickinson and Company) is a medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to rhumetoid arthritis in as little as 15 minutes test has been clinically validated at several hospitals and clinical laboratories in both the U.S. and China.

Key features of the study:

This report provides an in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global rheumatoid arthritis diagnostic tests market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Abbott Diagnostics (Abbott Laboratories), Labcorp ,Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Augurex Life Sciences Corp., Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global rheumatoid arthritis diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
- Serology Test
  - Erythrocyte Sedimentation Rate (ESR)
  - Rheumatoid Factor (RF)
  - Anti-cyclic Citrullinated Peptide (anti-CCP)
  - Antinuclear Antibody (ANA)
  - Uric Acid
  - Other Tests
- Monitoring RA Treatment Efficiency Tests
  - Salicylate Level Count
  - Muscle Enzyme Tests (CPK, Aldolase)
  - Creatinine Test
Global Rheumatoid Arthritis Diagnostic Tests Market, By End User:
- Diagnostic Laboratories
- Private Laboratories
- Public Laboratories
- Ambulatory Surgical Centers
Global Rheumatoid Arthritis Diagnostic Tests, By Region:
- North America
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB
- F. Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
Key Developments
PEST Analysis

4. Global Rheumatoid Arthritis Diagnostic Tests Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti-cyclic Citrullinated Peptide (anti-CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Tests
Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test

6. Global Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Rheumatoid Arthritis Diagnostic Tests Market, By Regions, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2018 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB,
- F.Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.